Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating
Elevance Health Inc. (NYSE:ELV) is one of the most undervalued large cap stocks to invest in now..
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 4,022,874 | $1,410,218,523 | +1% | 2.48% |
| 2. | Yacktman Asset Management Donald Yacktman | 328,756 | $115,245,416 | -2% | 1.61% |
| 3. | High Ground Investment Management Edgar Allen | 326,081 | $114,307,694 | +13% | 16.64% |
| 4. | Hosking Partners Jeremy Hosking | 144,548 | $50,671,301 | +2% | 1.72% |
| 5. | Polaris Capital Management Bernard Horn | 73,941 | $25,920,018 | -12% | 2.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $312.15 | 1,200 | $374,580.00 | 3,502 | 2025-08-19 | Filing | |
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,019,518 | $8,069,492,034 | 0.12% | |
| 2. | 2,360,858 | $827,598,772 | 0.27% | |
| 3. | 1,977,899 | $693,352,495 | 0.58% | |
| 4. | 949,000 | $332,671,950 | 0.2% | |
| 5. | 811,464 | $284,458,706 | 0.05% |
News See All
15 Most Undervalued Large Cap Stocks to Invest In Now
On January 21, Morgan Stanley chairman and CEO Ted Pick joined CNBC's 'Squawk Box' to discuss the latest market trends and suggested that the corporate health of large cap companies is excellent.
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth
Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now.
10 Cheap S&P 500 Stocks to Invest in Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC to suggest that she sees big 2026 upside beyond mega-cap tech.
Elevance Health (ELV) Fell Due to Reduced Guidance
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Can Elevance (ELV) Hike Prices to Accommodate Rising Costs?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Do Analysts Think About Elevance Health (ELV)?
Elevance Health, Inc. (NYSE:ELV) is one of the best affordable healthcare stocks to buy now. Elevance Health, Inc.
10 Best Affordable Healthcare Stocks to Buy Now
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real significant turnarounds in business, have performed pretty well, allowing certain...
BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations
On December 16, BofA lifted its price target on Elevance Health, Inc. (NYSE:ELV) to $385 from $370 and kept a Neutral rating.
Hedge Fund Resource Center Billionaire Hedge Funds
